WELLINGTON MANAGEMENT GROUP LLP - 31 Dec 2025 SCHEDULE 13G Report for Soleno Therapeutics, Inc. Common Stock (SLNO)

Filing Manager
WELLINGTON MANAGEMENT GROUP LLP
Reporting Manager
Wellington Management Group LLP
Security
Soleno Therapeutics, Inc. Common Stock
Symbol
SLNO
Shares outstanding
53,593,532 shares
Disclosed Ownership
3,322,799 shares
Ownership
6.2%
Form type
SCHEDULE 13G
Filing time
10 Feb 2026, 11:17:43 UTC
Date of event
31 Dec 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Wellington Management Group LLP 6.2% 3,322,799 0 3,088,720 Taisia Lowe Regulatory Analyst
Wellington Group Holdings LLP 6.2% 3,322,799 0 3,088,720 Taisia Lowe Regulatory Analyst
Wellington Investment Advisors Holdings LLP 6.2% 3,322,799 0 3,088,720 Taisia Lowe Regulatory Analyst
Wellington Management Company LLP 6% 3,322,799 0 3,081,174 Taisia Lowe Regulatory Analyst